HPQ enters its Q2 2026 results window — scheduled for May 27 — with an awkward split: the short position has edged down over the week, but the analyst community remains broadly negative and the stock is trading well above where most targets were set.
Short interest is elevated at 12.4% of the free float, representing roughly 115.9 million shares. That figure fell almost 5% over the week, continuing a drift lower from a local peak above 13.3% reached in early May. The pullback is gradual rather than forceful — shorts are trimming, not covering in size. Days to cover still runs at 9.6 days according to official FINRA data, reflecting a relatively illiquid exit if positions need to unwind quickly. The borrow market itself remains easy: availability is wide, cost to borrow is just 0.48% annually, and even at its one-week high of 0.51% it barely registers as a friction cost. There is no squeeze dynamic here. The ORTEX short score of 63.9 is running a touch below its recent peak of 65.9 hit on May 7, consistent with the slight easing of positioning this week.
Options sentiment is unremarkable, which in itself is informative. The put/call ratio is 0.96, fractionally below its 20-day average of 0.97 and carrying a z-score near zero. The 52-week range for the PCR runs from 0.62 to 1.66 — HPQ has looked far more hedged into prior events than it does now. Options traders are neither piling into protection nor expressing conviction to the upside. Relative to its own history, that reads as quiet indifference rather than any directional lean.
The Street is a different matter. The analyst consensus is a clean "hold," but the direction of travel has been uniformly bearish. The cluster of target cuts from February — Goldman Sachs, Morgan Stanley, Barclays, Wells Fargo, and BofA all lowered targets, several simultaneously on February 25 — left most published targets between $16 and $20. HPQ trades at $21.08 today, meaning the stock has rallied through those revised targets following the April 16 Q1 print, which pushed the stock up 3.4% on the day. BofA went further than most in February, downgrading to Underperform before the Q1 beat. The analyst data here is from late February, so no recent revisions have landed since Q1 results — something worth watching given the stock has moved 15% higher over the past month. A re-rating from one of the houses currently sitting at $16 targets would reprice the -10% return potential currently implied by consensus.
Valuation has compressed in the right direction for bulls. The EV/EBITDA multiple of 6.0x has drifted down over the past week and month, while the PE of 7.2x remains deeply modest for a large-cap tech hardware name — the forward earnings yield implied by the factor scores ranks in the 96th percentile of the broader universe on an EV/EBIT basis. The 12-month forward dividend yield is 5.6%, and the dividend score ranks at a perfect 100, suggesting the payout is well-supported. For income-oriented buyers, the valuation argument is straightforward. The complication is the growth picture: EPS momentum over both 30 and 90 days ranks in the bottom quartile, and forward EPS growth expectations rank only 13th percentile over three months. The stock is cheap on current earnings; the question is whether those earnings hold.
On the institutional side, BlackRock added a significant 10.4 million shares as of the end of April, making it the most actively moving of the top holders. Vanguard added a smaller 2.4 million. PRIMECAP added 3.8 million as of end of March. The pattern is passive and active managers alike nudging positions higher, though none of these moves suggest a high-conviction directional bet. Insider activity over the past 90 days has been negligible in dollar terms — a small net positive largely driven by award grants rather than open-market purchases.
Peers closed the week in mixed fashion. DELL surged 10.5% over the period, comfortably outperforming HPQ's flat week. HPE was barely changed, up 0.6%. The divergence with DELL is notable — Dell's print-driven rally has not carried across to HPQ in any meaningful way, suggesting the market is treating the two businesses as distinct stories rather than a rising-tide hardware moment.
The May 27 earnings date is the clear next waypoint. The past four prints have produced small near-term moves — the biggest was the April 16 Q1 gain of 3.4% — but each has finished the subsequent five days higher by 3-5%. How the stock behaves relative to targets that mostly sit below the current price will be the defining question heading into that release.
See the live data behind this article on ORTEX.
Open HPQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
